Hiper-Amonemix®

940 mg/g Granule

Product Details
Pharmaceutical Form:
Granulate for Oral Administration
Active Ingredient:
Sodium Phenylbutyrate
Commercial Form:
266 g HDPE package

Hiper-Amonemix® is used as adjunctive therapy in the chronic treatment of urea cycle disorders including carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase deficiencies.

450-600 mg/kg/day in newborns, infants and children weighing less than 20 kg. It is determined as 9.9-13.0 g/m2/day in children, adolescents and adults weighing more than 20 kg.